返回搜索

Regulation of PD-L1(CD274) transcription

Reactome ID: R-HSA-9909649

中文名称

PD-L1(CD274) 转录的调节

通路描述

CD274 (PD-L1/程序性死亡配体 1) 的转录调节在正常生理条件下调节正常 T 细胞功能方面起着关键作用,它提供免疫稳态。PD-L1 的表达受到各种转录因子和信号通路的严格控制,这些通路响应内在细胞信号和外在环境扰动。PD-L1 的转录调节涉及多种机制,包括表观遗传修饰 (EZH2, DNMTs, MLLs)、转录因子 (STAT3, STAT1, IRF1, MYC, HIF 等),这些因子响应多个上游信号通路而被激活。PD-L1 的转录调节是致癌信号通路、细胞因子反应、表观遗传修饰、特定转录因子、肿瘤微环境和非编码 RNA 之间复杂相互作用的结果。这种多面调节确保了 PD-L1 的表达可以精细调节以促进正常条件下的免疫耐受以及在癌症中的免疫逃逸,使其成为癌症免疫治疗的关键靶点 (Zhou 等人,2023; Cha 等人,2019; Yamaguchi 等人,2022; Ju 等人,2020)。
英文描述
Regulation of PD-L1(CD274) transcription The transcriptional regulation of CD274 (PD-L1/ programmed death-ligand 1) plays a critical role in the regulation of normal T cell function in normal physiological condition where it provides immune homeostasis. The expression of PD-L1 is tightly controlled by various transcription factors and signalling pathways, which respond to both intrinsic cellular signals and extrinsic environmental perturbations. PD-L1 is regulated transcriptionally by multiple mechanism like epigenetic modifications (EZH2, DNMTs, MLLs), transcription factors (STAT3. STAT1, IRF1, MYC, HIF and ither) which get activated in response to multiple upstream signalling pathways. The transcriptional regulation of PD-L1 is a complex interplay of oncogenic signalling pathways, cytokine responses, epigenetic modifications, specific transcription factors, the tumour microenvironment, and non-coding RNAs. This multifaceted regulation ensures that PD-L1 expression can be finely tuned to promote immunotolerance in normal condition as well as immune evasion in cancer, making it a critical target for cancer immunotherapy (Zhou et al.,2023, Cha et al.,2019, Yamaguchi et al.,2022, Ju et al.,2020)

所含基因

68 个基因